Status:
UNKNOWN
Development and Exploration of the Feasibility of Using Locally Synthesized Small Molecule Inhibitors to Treat Human Acute Leukemia Cells
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
Brief Summary
Acute leukemias are commonly seen in elderly and have no effective therapy. In recent years, small molecule inhibitors have shown a tremendous promise in cancer treatment such as chronic myeloid leuke...
Eligibility Criteria
Inclusion
- Acute Myeloid Leukemia
Exclusion
- Hematologic malignancies other than AML
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01142375
Start Date
April 1 2008
Last Update
June 11 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.